A systematic review of two‐stage hepatectomy in patients with initially unresectable colorectal liver metastases
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · cited 1×
“This systematic review was performed according to PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines.(17) Results”
MethodGlobal Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815 · cited 1×
“Partial response rates of up to 50% and median survival approaching 2 years have been reported.(49,50) The addition of biological agents such as bevacizumab and cetuximab has been shown to further improve response rate.”
BackgroundFong, Y., Fortner, J., Sun, R. L., Brennan, M. F., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199909000-00004 · Cited by 3,715
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431302 · Cited by 3,005
Tournigand, C., André, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., Quinaux, E., Couteau, C., Buyse, M., Ganem, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.113 · Cited by 2,915
Abdalla, E. K., Vauthey, J.-N., Ellis, L. M., Ellis, V., Pollock, R., Broglio, K. R., Hess, K., & Curley, S. A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000128305.90650.71 · Cited by 1,750
Nordlinger, B., Guiguet, M., Vaillant, J.-C., Balladur, P., Boudjema, K., Bachellier, P., Jaeck, D., & Association Française de Chirurgie (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1254::aid-cncr5>3.0.co;2-i · Cited by 1,722
Resection of colorectal liver metastases
Scheele, J., Stang, R., Altendorf‐Hofmann, A., & Paul, M. (1995) · World Journal of Surgery · doi:10.1007/bf00316981 · Cited by 1,539
Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases
Choti, M. A., Sitzmann, J. V., Tiburi, M. F., Sumetchotimetha, W., Rangsin, R., Schulick, R. D., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (2002) · Annals of Surgery · doi:10.1097/00000658-200206000-00002 · Cited by 1,454
Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure
Tomlinson, J. S., Jarnagin, W. R., DeMatteo, R. P., Fong, Y., Kornprat, P., Gonen, M., Kemeny, N., Brennan, M. F., Blumgart, L. H., & D'Angelica, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.0833 · Cited by 1,187
Rees, M., Tekkis, P. P., Welsh, F. K. S., O'Rourke, T., & John, T. G. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815aa2c2 · Cited by 1,026
Adam, R., Pascal, G., Castaing, D., Azoulay, D., Delvart, V., Paule, B., Levi, F., & Bismuth, H. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000145964.08365.01 · Cited by 1,001
Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant Chemotherapy
Bismuth, H., Adam, R., Lévi, F., Farabos, C., Waechter, F., Castaing, D., Majno, P., & Engerran, L. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00009 · Cited by 963
Folprecht, G., Gruenberger, T., Bechstein, W. O., Raab, H.-R., Lordick, F., Hartmann, J. T., Lang, H., Frilling, A., Stoehlmacher, J., Weitz, J., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70330-4 · Cited by 963 · cited 2×
“Similarly, up to a third of patients initially labelled as unresectable are reclassified as resectable following review by a multidisciplinary oncology team.(46) This lack of agreement even among experts significantly limits the critical evaluation of outcomes of TSH in patients with initially unresectable CLM.”
BackgroundTwo-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors
Adam, R., Laurent, A., Azoulay, D., Castaing, D., & Bismuth, H. (2000) · Annals of Surgery · doi:10.1097/00000658-200012000-00006 · Cited by 801 · cited 1×
“published the first series of two-stage hepatectomies (TSHs) in patients with unresectable bilobar CLM that were not amenable to resection in a single operation, even in combination with preoperative chemotherapy and portal vein embolization (PVE).(14) Two-stage hepatectomy is conceived as a planned and potentially cu…”
BackgroundPortal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial
Farges, O., Belghiti, J., Kianmanesh, R., Marc Regimbeau, J., Santoro, R., Vilgrain, V., Denys, A., & Sauvanet, A. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000048447.16651.7b · Cited by 676 · cited 1×
“Previous reports have demonstrated that the uniform delivery of PVE before major liver resection does not influence postoperative morbidity or mortality.(60) Portal vein embolization is therefore indicated only in patients in whom liver resection is technically feasible but would leave an insufficient FLR volume.”
ResultMinagawa, M., Makuuchi, M., Torzilli, G., Takayama, T., Kawasaki, S., Kosuge, T., Yamamoto, J., & Imamura, H. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00006 · Cited by 663
Fernandez, F. G., Drebin, J. A., Linehan, D. C., Dehdashti, F., Siegel, B. A., & Strasberg, S. M. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000138076.72547.b1 · Cited by 621
Blazer, D. G., Kishi, Y., Maru, D. M., Kopetz, S., Chun, Y. S., Overman, M. J., Fogelman, D., Eng, C., Chang, D. Z., Wang, H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5299 · Cited by 604 · cited 13×
“This systematic review was undertaken to assess the published evidence for the safety and efficacy of TSH in patients with initially unresectable CLM. HPB 2013, 15, 483–491 © 2012 International Hepato-Pancreato-Biliary Association”
BackgroundInfluentialTraditional reviews, meta-analyses and pooled analyses in epidemiology
Blettner, M. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.1.1 · Cited by 594 · cited 1×
“The application of any formal metaanalytic methods, particularly simple pooling, to observational studies has been considered controversial.(61) Although combining data by meta-analytic methods is preferable, it was not feasible in this study.”
MethodAzoulay, D., Castaing, D., Smail, A., Adam, R., Cailliez, V., Laurent, A., Lemoine, A., & Bismuth, H. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00005 · Cited by 539
Van Cutsem, E., Rivera, F., Berry, S., Kretzschmar, A., Michael, M., DiBartolomeo, M., Mazier, M.-A., Canon, J.-L., Georgoulias, V., Peeters, M., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp233 · Cited by 532 · cited 1×
“Around 25% of patients have synchronous liver metastases at presentation and a further 25–50% subsequently develop metachronous liver disease.(2,3) Surgical resection of colorectal liver metastases (CLM) is considered the only curative therapy and achieves 5-year overall survival (OS) rates of up to 58%.”
BackgroundResection of Hepatic Metastases from Colorectal Cancer Biologic Perspectives
STEELE, G., & RAVIKUMAR, T. S. (1989) · Annals of Surgery · doi:10.1097/00000658-198908000-00001 · Cited by 525
Brouquet, A., Abdalla, E. K., Kopetz, S., Garrett, C. R., Overman, M. J., Eng, C., Andreou, A., Loyer, E. M., Madoff, D. C., Curley, S. A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.6132 · Cited by 396 · cited 16×
“A total of 107 patients did not progress to the second stage of TSH.”
BackgroundInfluentialSelection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement
Charnsangavej, C., Clary, B., Fong, Y., Grothey, A., Pawlik, T. M., & Choti, M. A. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9023-y · Cited by 354 · cited 1×
“Three specific criteria for resectability of CLM were proposed: (i) the preservation of two contiguous liver segments; (ii) the preservation of adequate vascular inflow and outflow and biliary drainage, and (iii) the preservation of an adequate FLR (> 20% in a healthy liver).(47) The widespread adoption of uniform def…”
BackgroundLong-Term Results of Two-Stage Hepatectomy for Irresectable Colorectal Cancer Liver Metastases
Wicherts, D. A., Miller, R., de Haas, R. J., Bitsakou, G., Vibert, E., Veilhan, L.-A., Azoulay, D., Bismuth, H., Castaing, D., & Adam, R. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181907fd9 · Cited by 332
Extending the Frontiers of Surgical Therapy for Hepatic Colorectal Metastases: Is There a Limit?
Khatri, V. P., Petrelli, N. J., & Belghiti, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6155 · Cited by 272 · cited 13×
“This systematic review was undertaken to assess the published evidence for the safety and efficacy of TSH in patients with initially unresectable CLM. HPB 2013, 15, 483–491 © 2012 International Hepato-Pancreato-Biliary Association”
BackgroundInfluentialResection of liver metastases—When is it worthwhile?
Adson, M. A. (1987) · World Journal of Surgery · doi:10.1007/bf01655817 · Cited by 249
Masi, G., Loupakis, F., Salvatore, L., Fornaro, L., Cremolini, C., Cupini, S., Ciarlo, A., Del Monte, F., Cortesi, E., Amoroso, D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70175-3 · Cited by 239 · cited 1×
“The addition of biological agents such as bevacizumab and cetuximab has been shown to further improve response rate.(46,51) One systematic review demonstrated Table 4 Survival outcomes after completion of two-stage hepatectomy”
BackgroundViganò, L., Ferrero, A., Lo Tesoriere, R., & Capussotti, L. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9935-9 · Cited by 203
Lam, V. W. T., Spiro, C., Laurence, J. M., Johnston, E., Hollands, M. J., Pleass, H. C. C., & Richardson, A. J. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2061-0 · Cited by 186 · cited 1×
“that downstaging chemotherapy could convert almost a quarter of patients with initially unresectable CLM into resection candidates.(43) Despite the increased efficacy of chemotherapy in patients with CLM, its use is not without risk.”
BackgroundSelf-citationUrgent Need for a New Staging System in Advanced Colorectal Cancer
Poston, G. J., Figueras, J., Giuliante, F., Nuzzo, G., Sobrero, A. F., Gigot, J.-F., Nordlinger, B., Adam, R., Gruenberger, T., Choti, M. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.6453 · Cited by 159
Khan, A. Z., Morris‐Stiff, G. J., & Makuuchi, M. (2008) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-008-0016-z · Cited by 153
In defense of Pierre Louis who pioneered the epidemiological approach to good medicine
Morabia, A. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.07.007 · Cited by 149
Two-stage hepatectomy for multiple bilobar colorectal liver metastases
Narita, M., Oussoultzoglou, É., Jaeck, D., Fuchschuber, P., Rosso, E., Pessaux, P., Marzano, E., & Bachellier, P. (2011) · British journal of surgery · doi:10.1002/bjs.7580 · Cited by 149 · cited 2×
“Five studies reported the rate of response to preoperative chemotherapy; partial response was achieved in 130 of 222 patients (59%; range: 43–73%) and stable response was achieved in 86 of 222 patients (39%; range: 19–57%).(19,20,23,24,27) The surgical characteristics and perioperative outcomes of the first stage of T…”
BackgroundSimple Pooling versus Combining in Meta-Analysis
Bravata, D. M., & Olkin, I. (2001) · Evaluation & the Health Professions · doi:10.1177/01632780122034885 · Cited by 147 · cited 1×
“Although combining data by meta-analytic methods is preferable, it was not feasible in this study.(62) It should be acknowledged that the studies in this review each included a small number of resectable patients and that considerable heterogeneity was evident across designs.”
MethodElias, D. M., Baton, O., Sidéris, L., Boige, V., Malka, D., Liberale, G., Pocard, M. D., & Lasser, P. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20237 · Cited by 143
Two-stage Hepatectomy Approach for Initially Unresectable Colorectal Hepatic Metastases
Adam, R. A., Miller, R., Pitombo, M. B., Wicherts, D. A., de Haas, R. J., Bitsakou, G., & Aloia, T. A. (2007) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2007.04.016 · Cited by 126 · cited 1×
“proposed a classification of multinodular CLM depending on the number, size and location of metastases.(48) It was suggested that TSH should be considered in selected patients with bilobar multinodular CLM in whom a right hepatectomy would leave more than three metastases or any metastasis of >3 cm in the FLR.”
Morris‐Stiff, G. J., Tan, Y.-M., & Vauthey, J. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.07.007 · Cited by 123 · cited 1×
“Increased perioperative bleeding has been associated with chemotherapy-associated sinusoidal liver injury.(53) Vauthey et al.”
BackgroundThe Role of Preoperative Chemotherapy in Patients with Resectable Colorectal Liver Metastases
Benoist, S., & Nordlinger, B. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0492-7 · Cited by 122 · cited 1×
“The rationale for preoperative chemotherapy includes an opportunity to demonstrate chemotherapy-specific efficacy as well as a lower rate of positive margins.(55) The objective response to preoperative chemotherapy has also been shown to be a strong predictor of survival after resection of CLM.”
BackgroundPulitanò, C., Castillo, F., Aldrighetti, L. A., Bodingbauer, M., Parks, R. W., Ferla, G., Wigmore, S. J., & Garden, O. J. (2010) · HPB · doi:10.1111/j.1477-2574.2010.00155.x · Cited by 105
Karoui, M., Viganò, L., Goyer, P., Ferrero, A., Luciani, A., Aglietta, M., Delbaldo, C., Cirillo, S., Capussotti, L., & Cherqui, D. (2010) · British journal of surgery · doi:10.1002/bjs.7128 · Cited by 92
Homayounfar, K., Liersch, T., Schuetze, G., Niessner, M., Goralczyk, A. D., Meller, J., Langer, C., Ghadimi, Β. M., Becker, H., & Lorf, T. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0620-z · Cited by 56 · cited 1×
“Three studies with overlapping patient series were excluded, as was one study without longterm survival data.(31) Three studies from the same institution reporting the use of ablation of CLM only at the first stage of TSH were excluded.”
ResultPamecha, V., Nedjat-Shokouhi, B., Gurusamy, K. S., Glantzounis, G. K., Sharma, D., & Davidson, B. R. (2008) · Digestive Surgery · doi:10.1159/000176063 · Cited by 55 · cited 2×
“Pamecha et al.(19) 43 12 NR NR NR 33 70 50”
BackgroundSummary outcomes of two‐stage resection for advanced colorectal liver metastases
Chua, T. C., Liauw, W., Chu, F., & Morris, D. L. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23170 · Cited by 51
Mohammad, W. M., Martel, G., Mimeault, R., Fairfull-Smith, R. J., Auer, R. C., & Balaa, F. K. (2012) · HPB · doi:10.1111/j.1477-2574.2012.00440.x · Cited by 44 · cited 13×
“This systematic review was undertaken to assess the published evidence for the safety and efficacy of TSH in patients with initially unresectable CLM. HPB 2013, 15, 483–491 © 2012 International Hepato-Pancreato-Biliary Association”
BackgroundInfluentialTwo-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor.
Lygidakis, N. J., Singh, G., Bardaxoglou, E., Dedemadi, G., Sgourakis, G. G., Nestoridis, J., Malliotakis, A., Pedonomou, M., Solomou, E., Safioleas, M. C., et al. (2004) · PubMed · Cited by 14
Tanaka, K., Kumamoto, T., Nojiri, K., Takeda, K., Ichikawa, Y., & Endo, I. (2012) · World Journal of Surgery · doi:10.1007/s00268-012-1578-0 · Cited by 7
Cited by
Sandström, P., Røsok, B. I., Sparrelid, E., Larsen, P. N., Larsson, A. L., Lindell, G., Schultz, N. A., Bjørnbeth, B. A., Isaksson, B., Rizell, M., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002511 · Cited by 337
Alvarez, F. A., Ardiles, V., de Santibañes, M., Pekolj, J., & de Santibañes, E. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001046 · Cited by 167
Current status of surgical treatment of colorectal liver metastases
Xu, F., Tang, B., Jin, T.-Q., & Dai, C.-L. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i14.716 · Cited by 45
Metadata
- Authors
- Lam, V. W. T., Laurence, J. M., Johnston, E., Hollands, M. J., Pleass, H. C. C., & Richardson, A. J.
- Venue
- HPB
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 15
- Issue
- 7
- Pages
- 483-491
- ISSN
- 1365-182X (ISSN-L)
- OpenAlex
- W2027489206
- Cited by
- 194
- References
- 51
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.